Tuesday, May 22, 2018

FDA Eyes Limits on 503B Bulk Substances List

FDA Eyes Limits on 503B Bulk Substances List

Pharmacy Practice News-8 hours ago
An FDA draft guidance limiting the bulk drug substances that 503B facilities can use in compounding may trigger several unintended consequences, including a .
Post a Comment